The role of allogeneic stem-cell transplant in myelofibrosis in the era of JAK inhibitors: a case-based review

Allogeneic hematopoietic stem-cell transplantation (HSCT) is, at present, the only potentially curative therapy for myelofibrosis (MF). Despite many improvements, outcomes of HSCT are still burdened by substantial morbidity and high transplant-related mortality. Allogeneic transplant is generally co...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiribelli, Mario, Palandri, Francesca, Sant’Antonio, Emanuela, Breccia, Massimo, Bonifacio, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113188/
https://www.ncbi.nlm.nih.gov/pubmed/31534197
http://dx.doi.org/10.1038/s41409-019-0683-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113188/
https://www.ncbi.nlm.nih.gov/pubmed/31534197
http://dx.doi.org/10.1038/s41409-019-0683-1

Ejemplares similares